Keywords
Last Name
Institution

Natalia V. Oleinik

Title
InstitutionMedical University of South Carolina
DepartmentBiochemistry and Molecular Biology
AddressP.O. Box MSC 509
509
Hollings Cancer Center - 86 Jonathan Lucas St.
Phone843-792-0941
Fax843-792-8565
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Qie S, Yoshida A, Parnham S, Oleinik N, Beeson GC, Beeson CC, Ogretmen B, Bass AJ, Wong KK, Rustgi AK, Diehl JA. Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma. Nat Commun. 2019 03 21; 10(1):1296. PMID: 30899002.
      View in: PubMed
    2. Nganga R, Oleinik N, Kim J, Selvam SP, De Palma R, Johnson KA, Parikh RY, Gangaraju V, Peterson Y, Dany M, Stahelin RV, Voelkel-Johnson C, Szulc ZM, Bieberich E, Ogretmen B. Receptor-interacting Ser/Thr kinase 1 (RIPK1) and myosin IIA-dependent ceramidosomes form membrane pores that mediate blebbing and necroptosis. J Biol Chem. 2019 01 11; 294(2):502-519. PMID: 30420430.
      View in: PubMed
    3. Nganga R, Oleinik N, Ogretmen B. Mechanisms of Ceramide-Dependent Cancer Cell Death. Adv Cancer Res. 2018; 140:1-25. PMID: 30060806.
      View in: PubMed
    4. Gencer S, Oleinik N, Kim J, Panneer Selvam S, De Palma R, Dany M, Nganga R, Thomas RJ, Senkal CE, Howe PH, Ogretmen B. TGF-ß receptor I/II trafficking and signaling at primary cilia are inhibited by ceramide to attenuate cell migration and tumor metastasis. Sci Signal. 2017 Oct 24; 10(502). PMID: 29066540.
      View in: PubMed
    5. Thomas RJ, Oleinik N, Panneer Selvam S, Vaena SG, Dany M, Nganga RN, Depalma R, Baron KD, Kim J, Szulc ZM, Ogretmen B. HPV/E7 induces chemotherapy-mediated tumor suppression by ceramide-dependent mitophagy. EMBO Mol Med. 2017 08; 9(8):1030-1051. PMID: 28606997.
      View in: PubMed
    6. Dany M, Gencer S, Nganga R, Thomas RJ, Oleinik N, Baron KD, Szulc ZM, Ruvolo P, Kornblau S, Andreeff M, Ogretmen B. Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML. Blood. 2016 10 13; 128(15):1944-1958. PMID: 27540013.
      View in: PubMed
    7. Panneer Selvam S, De Palma RM, Oaks JJ, Oleinik N, Peterson YK, Stahelin RV, Skordalakes E, Ponnusamy S, Garrett-Mayer E, Smith CD, Ogretmen B. Binding of the sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylation. Sci Signal. 2015 Jun 16; 8(381):ra58. PMID: 26082434.
      View in: PubMed
    8. Oleinik NV, Helke KL, Kistner-Griffin E, Krupenko NI, Krupenko SA. Rho GTPases RhoA and Rac1 mediate effects of dietary folate on metastatic potential of A549 cancer cells through the control of cofilin phosphorylation. J Biol Chem. 2014 Sep 19; 289(38):26383-94. PMID: 25086046.
      View in: PubMed
    9. Prakasam A, Ghose S, Oleinik NV, Bethard JR, Peterson YK, Krupenko NI, Krupenko SA. JNK1/2 regulate Bid by direct phosphorylation at Thr59 in response to ALDH1L1. Cell Death Dis. 2014 Jul 31; 5:e1358. PMID: 25077544.
      View in: PubMed
    10. DebRoy S, Kramarenko II, Ghose S, Oleinik NV, Krupenko SA, Krupenko NI. A novel tumor suppressor function of glycine N-methyltransferase is independent of its catalytic activity but requires nuclear localization. PLoS One. 2013; 8(7):e70062. PMID: 23936142.
      View in: PubMed
    11. Hoeferlin LA, Oleinik NV, Krupenko NI, Krupenko SA. Activation of p21-Dependent G1/G2 Arrest in the Absence of DNA Damage as an Antiapoptotic Response to Metabolic Stress. Genes Cancer. 2011 Sep; 2(9):889-99. PMID: 22593801.
      View in: PubMed
    12. Oleinik NV, Krupenko NI, Krupenko SA. Epigenetic Silencing of ALDH1L1, a Metabolic Regulator of Cellular Proliferation, in Cancers. Genes Cancer. 2011 Feb; 2(2):130-9. PMID: 21779486.
      View in: PubMed
    13. Strickland KC, Holmes RS, Oleinik NV, Krupenko NI, Krupenko SA. Phylogeny and evolution of aldehyde dehydrogenase-homologous folate enzymes. Chem Biol Interact. 2011 May 30; 191(1-3):122-8. PMID: 21215736.
      View in: PubMed
    14. Oleinik NV, Krupenko NI, Krupenko SA. ALDH1L1 inhibits cell motility via dephosphorylation of cofilin by PP1 and PP2A. Oncogene. 2010 Nov 25; 29(47):6233-44. PMID: 20729910.
      View in: PubMed
    15. Krupenko NI, Dubard ME, Strickland KC, Moxley KM, Oleinik NV, Krupenko SA. ALDH1L2 is the mitochondrial homolog of 10-formyltetrahydrofolate dehydrogenase. J Biol Chem. 2010 Jul 23; 285(30):23056-63. PMID: 20498374.
      View in: PubMed
    16. Strickland KC, Hoeferlin LA, Oleinik NV, Krupenko NI, Krupenko SA. Acyl carrier protein-specific 4'-phosphopantetheinyl transferase activates 10-formyltetrahydrofolate dehydrogenase. J Biol Chem. 2010 Jan 15; 285(3):1627-33. PMID: 19933275.
      View in: PubMed
    17. Ghose S, Oleinik NV, Krupenko NI, Krupenko SA. 10-formyltetrahydrofolate dehydrogenase-induced c-Jun-NH2-kinase pathways diverge at the c-Jun-NH2-kinase substrate level in cells with different p53 status. Mol Cancer Res. 2009 Jan; 7(1):99-107. PMID: 19147541.
      View in: PubMed
    18. Oleinik NV, Krupenko NI, Krupenko SA. Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway. Oncogene. 2007 Nov 08; 26(51):7222-30. PMID: 17525747.
      View in: PubMed
    19. Oleinik NV, Krupenko NI, Reuland SN, Krupenko SA. Leucovorin-induced resistance against FDH growth suppressor effects occurs through DHFR up-regulation. Biochem Pharmacol. 2006 Jul 14; 72(2):256-66. PMID: 16712799.
      View in: PubMed
    20. Oleinik NV, Krupenko NI, Priest DG, Krupenko SA. Cancer cells activate p53 in response to 10-formyltetrahydrofolate dehydrogenase expression. Biochem J. 2005 Nov 01; 391(Pt 3):503-11. PMID: 16014005.
      View in: PubMed
    21. Oleinik NV, Krupenko SA. Ectopic expression of 10-formyltetrahydrofolate dehydrogenase in A549 cells induces G1 cell cycle arrest and apoptosis. Mol Cancer Res. 2003 Jun; 1(8):577-88. PMID: 12805405.
      View in: PubMed
    22. Krupenko SA, Oleinik NV. 10-formyltetrahydrofolate dehydrogenase, one of the major folate enzymes, is down-regulated in tumor tissues and possesses suppressor effects on cancer cells. Cell Growth Differ. 2002 May; 13(5):227-36. PMID: 12065246.
      View in: PubMed
    23. Smirnova OV, Olenik IV, Rozen VB. [Regularities in androgen reception in rat liver and its role in realizing direct androgenous effects]. Biokhimiia. 1991 Apr; 56(4):681-6. PMID: 1912071.
      View in: PubMed
    24. Oleinik NV, Smirnova OV, Rozen VB. [The role of the hypophysis and STH in the regulation of the androgenic receptor level of the rat liver and in the realization of the sex-differentiating action of gonadal hormones]. Probl Endokrinol (Mosk). 1990 Sep-Oct; 36(5):78-82. PMID: 1964217.
      View in: PubMed
    25. Oleinik NV, Smirnova OV, Rozen VB. [The characteristics of the sex-differentiating action of sex steroids on the androgen receptors of the rat liver]. Probl Endokrinol (Mosk). 1990 May-Jun; 36(3):61-6. PMID: 2395839.
      View in: PubMed
    26. Smirnova OV, Oleinik NV, El'chaninova SA, Rozen VB. [Demonstration of a sex differentiation in the content of androgen receptors in the liver cytosol of rats]. Probl Endokrinol (Mosk). 1988 Jul-Aug; 34(4):68-72. PMID: 3264067.
      View in: PubMed
    Oleinik's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _